South Korean E-cigarette Association sues government for economic damages.

Oct.17.2022
South Korean E-cigarette Association sues government for economic damages.
South Korea's electronic cigarette association has sued the government for causing economic losses to small e-cigarette businesses with incorrect information.

The Korean e-cigarette association has filed a lawsuit against the government, accusing it of causing economic losses to small business owners involved in the e-cigarette industry by providing incorrect information.


The Korea E-cigarette Association (KECA) has accused the government's health agency, the Ministry of Health and Welfare (MOHW), of damaging the reputation of small e-cigarette businesses and causing financial problems by urging the public to stop using liquid e-cigarettes in a press release dated February 23, 2019. KECA claimed that the basis for MOHW's decision was a notice from the US Food and Drug Administration (FDA) prohibiting the sale of liquid e-cigarettes due to the use of tetrahydrocannabinol, a main culprit in the US outbreak of severe lung illness associated with vaping that claimed eight lives and resulted in a ban on vaping products by the FDA in 2019. The South Korean Health Ministry, however, confirmed only one suspected case of lung injury related to e-cigarettes at the time of the press release and said that even that case was suspected to be from a smoker. According to a study published in the Journal of Korean Medical Science in December 2021, there have been no cases of severe pneumonia or lung injuries among users of liquid e-cigarettes. Despite these findings, KECA criticized the Health Ministry for not withdrawing its strong recommendation to suspend the use of liquid e-cigarettes and accused them of neglecting their duty. KECA also took issue with a press release issued by the Korean Disease Control and Prevention Agency (KDCA) on July 21, titled "Liquid E-cigarettes Disperse More and Farther Fine Dust than Cigarettes," saying that the measurements of fine dust by the KDCA were unavoidably higher in areas of higher humidity due to the method used in measuring them. KECA further argued that the comparison of liquid e-cigarettes and tobacco in the same environment is an inappropriate research method that fails to consider the unique characteristics of liquid e-cigarettes. KECA maintained that the government has already acknowledged that e-cigarettes are safer than tobacco, citing a 2017 test by the Ministry of Food and Drug Safety (MFDS) that found harmful substances in liquid e-cigarettes to be much lower than those in tobacco. KECA also pointed out that no tar or carbon monoxide was detected in liquid e-cigarettes, and the levels of formaldehyde and acetaldehyde were 1/20th and 1/500th those in cigarettes, respectively. Despite the significant differences in harmful substance contents, KECA protested that the Health Ministry's anti-smoking campaign has created a false perception that liquid e-cigarettes are as harmful as tobacco, causing great economic and psychological harm to e-cigarette business owners. KECA's Vice President Kim Du-hwan stated that KECA would do its utmost to win a legal battle against the government by preparing all scientific evidence and logical arguments to address the unfair treatment of small e-cigarette business owners who are unable to voice their concerns. A spokesperson for the Health Ministry responded to the lawsuit by stating that the relevant authorities would thoroughly examine the details of the complaint and work with other agencies such as KDCA and MFDS to address the issues.


Statement:


This article is compiled from third-party information and is intended solely for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only for industry-related communication and research purposes.


Due to limitations in our translation abilities, this article may not accurately reflect the original text. Please refer to the original version for precise information.


2FIRSTS maintains complete alignment with the Chinese government in its positions and statements regarding domestic, Hong Kong, Macau, Taiwan, and foreign issues.


The ownership of the compiled information belongs to the original media and authors. If there are any copyright infringements, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race
Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race
Nicokick.com said it will continue its collaboration with zone for a second year at the April 19 NASCAR race in Kansas City, appearing on Richard Childress Racing’s No. 8 Chevrolet driven by Kyle Busch. The 2026 race-weekend campaign for verified adult nicotine consumers aged 21 and older includes the exclusive launch of zone Cranberry and a limited-edition five-flavor mix pack selected by Busch.
Apr.16 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Study Says Europe’s Illicit Disposable Vape Market to Reach EUR 6.6 Billion in 2026
Study Says Europe’s Illicit Disposable Vape Market to Reach EUR 6.6 Billion in 2026
A new study by the Fraunhofer Institute says the rapidly expanding illicit market for disposable e-cigarettes is undermining European regulation, fuelling youth vaping and causing significant tax losses. The study says the illicit market is worth EUR 6.6 billion in 2026 and is projected to rise to EUR 10.8 billion by 2030. It adds that a significant share of the disposable vape market now operates outside the regulatory framework established by the EU Tobacco Products Directive.
Mar.13 by 2FIRSTS.ai
Singapore New bill would raise maximum fines to S$200,000 for sellers and S$300,000 for smugglers
Singapore New bill would raise maximum fines to S$200,000 for sellers and S$300,000 for smugglers
A bill introduced in Singapore’s Parliament on Feb. 12 proposes major increases in penalties for vaping-related offences, including higher maximum fines for users, sellers and smugglers. The draft would also rename the current Tobacco (Control of Advertisements and Sale) Act as the Tobacco and Vaporisers Control Act.
Feb.28 by 2FIRSTS.ai
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
On March 13, 2026, R.J. Reynolds and related companies filed an appeal with the U.S. Court of Appeals for the Federal Circuit, seeking review of the U.S. International Trade Commission’s final ruling in the disposable vape Section 337 investigation.
Mar.16 by 2FIRSTS.ai
Special Report | Tax Veteran Takes Helm at China’s Tobacco Regulator, Leadership Change Fuels Reform Watch
Special Report | Tax Veteran Takes Helm at China’s Tobacco Regulator, Leadership Change Fuels Reform Watch
China’s tobacco system has appointed a new top internal leader with a long background in public finance and taxation, drawing renewed attention to whether the country’s tobacco monopoly may enter a new phase of reform debate. The appointment itself does not signal a defined policy shift.But it places a veteran fiscal official at the center of a key state sector amid unresolved questions on tax reform, structure, and emerging tobacco products.
Mar.20